Amarin Corp Plcuk (AMRN) Finished Goods (2012 - 2021)
Amarin Corp Plcuk (AMRN) posted quarterly Finished Goods of $197.9 million for Q3 2021, up 114.68% YoY from $92.2 million in Q3 2020, and up 25.99% sequentially from $157.1 million in Q2 2021.
Amarin Corp Plcuk (AMRN) Finished Goods (2012 - 2021) Analysis & Trends
Amarin Corp Plcuk has disclosed Finished Goods across 9 years of filings, most recently posting $197.9 million for Q3 2021.
- In Q3 2021, Finished Goods rose 114.68% year-over-year to $197.9 million; the TTM figure through Sep 2021 stood at $197.9 million (up 114.68% YoY), while the FY2020 annual figure was $107.8 million, up 138.1% from the prior year.
- Finished Goods climbed to $197.9 million in Q3 2021, from $157.1 million in the prior quarter.
- Over the last five years, Finished Goods for AMRN reached as high as $197.9 million in Q3 2021 and fell as low as $7.4 million in Q2 2017.
- The 4-year median for Finished Goods is $58.5 million (2020), against an average of $73.7 million.
- The widest YoY moves for Finished Goods: up 313.8% in 2017, down 17.76% in 2017.
- A 4-year view of Finished Goods shows it stood at $12.4 million in 2017, then soared by 266.01% to $45.3 million in 2019, then jumped by 138.1% to $107.8 million in 2020, then jumped by 83.56% to $197.9 million in 2021.
- According to Business Quant data, Finished Goods over the past three periods registered $197.9 million, $157.1 million, and $125.3 million for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 197.91 Mn |
| Jun 30, 2021 | 157.08 Mn |
| Mar 31, 2021 | 125.34 Mn |
| Dec 31, 2020 | 107.82 Mn |
| Sep 30, 2020 | 92.19 Mn |
| Jun 30, 2020 | 65.67 Mn |
| Mar 31, 2020 | 51.34 Mn |
| Dec 31, 2019 | 45.28 Mn |
| Dec 31, 2017 | 12.37 Mn |
| Sep 30, 2017 | 13.52 Mn |
| Jun 30, 2017 | 7.37 Mn |
| Mar 31, 2017 | 8.67 Mn |
| Dec 31, 2016 | 5.36 Mn |
| Sep 30, 2016 | 3.27 Mn |
| Jun 30, 2016 | 8.96 Mn |
| Mar 31, 2016 | 2.77 Mn |
| Dec 31, 2015 | 8.25 Mn |
| Sep 30, 2015 | 12.42 Mn |
| Jun 30, 2015 | 5.39 Mn |
| Dec 31, 2014 | 3.75 Mn |